ArticleNaunyn-Schmiedeberg's archives of pharmacology2024

Fenofibrate suppresses the progression of hepatoma by downregulating osteopontin through inhibiting the PI3K/AKT/Twist pathway.

Weiqing Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.